Senior Research Fellow & Deputy Head - Sexual Health Unit
The University of Melbourne, Australia
Rates of sexually transmitted infections (STIs) continue to rise across the world and interventions are essential to reduce their incidence. Past and recent studies have indicated this may be achieved using doxycycline postexposure prophylaxis (PEP) and this has sparked considerable interest in its use. However, many unanswered questions remain as to its long-term effects and particularly potentially negative impact on human microbiomes and antimicrobial resistance among STIs, other pathogens, and commensals. In this talk, Idiscuss seven areas of concern pertaining to the widespread use of doxycycline PEP.